Geriatric Oncology: Chemotherapy Toxicity in the Geriatric Population

EVENT DETAILS AND REGISTRATION

Date:September 01, 2016

Time: 05:30 PM - 08:00 PM (PT)

Location:Visitor Center, City of Hope, Duarte, CA

Event Is:

  1. Integrate a comprehensive geriatric assessment (CGA) into the evaluation of the elderly patient; to include such factors as comorbidity, functional status, physical performance, cognitive status, nutritional status, medication review, and social support.
  2. Assess an individual patient's risk of severe toxicity from chemotherapy by utilizing the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score.
  3. Demonstrate the utility of a greater awareness of geriatric assessment, which will aid in appropriate drug therapy selection and dosing based not just on pharmacology, but on individual patient physiology, thereby allowing a greater number of older cancer patients to benefit from treatment with reduced and manageable morbidity.
  4. Implement an individualized cooperative multidisciplinary treatment plan for the geriatric oncology patient.

Presenters:

Arti Hurria, MD • Director, Cancer and Aging Research Program • Co-leader, Cancer Control and Population Sciences Program • Associate Professor, Department of Medical Oncology & Therapeutics Research and Department of Population Sciences Dane

ADDITIONAL DETAILS:

Objectives:

  1. Integrate a comprehensive geriatric assessment (CGA) into the evaluation of the elderly patient; to include such factors as comorbidity, functional status, physical performance, cognitive status, nutritional status, medication review, and social support.
  2. Assess an individual patient's risk of severe toxicity from chemotherapy by utilizing the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score.
  3. Demonstrate the utility of a greater awareness of geriatric assessment, which will aid in appropriate drug therapy selection and dosing based not just on pharmacology, but on individual patient physiology, thereby allowing a greater number of older cancer patients to benefit from treatment with reduced and manageable morbidity.
  4. Implement an individualized cooperative multidisciplinary treatment plan for the geriatric oncology patient.

Who should attend:

Medical Oncologists, Radiation Oncologists, Gerontologists, Internists, and other allied health care professionals who treat geriatric patients with cancer.

CME credits:1.5 - AMA PRA Category 1TM

R.S.V.P.: Click here to register

Web Link:https://cme.cityofhope.org/eventinfo_7372.html

Contact:

Continuing Medical Education Department